Home  >  News
  Health Elite Club to distribute Cardax’s ZanthoSyn in China,   February 20, 2018
  Diurnal inks marketing agreement with Emerge for alkindi, chronocort in Australia and New Zealand,   February 19, 2018
  US FDA grants marketing nod for first blood test to aid in evaluation of concussion in adults,   February 16, 2018
  Diurnal gets European marketing authorisation for Alkindi as replacement therapy for paediatric adrenal insufficiency,   February 16, 2018
  GC Pharma, Lee's Pharm ink licensing agreement to develop and commercialise anticoagulant GCC-4401C,   February 15, 2018
  US FDA allows marketing of Viz. AI Contact application software for alerting potential stroke in patients,   February 15, 2018
  Teva launches Qvar Redihaler inhalation aerosol in US market,   February 14, 2018
  Janssen submits marketing authorisation application for apalutamide to treat patients with EMA,   February 13, 2018
  Norgine receives German regulatory approval for Plenvu for bowel cleansing in adults,   February 12, 2018
  Pii and its partners receives US FDA marketing approval for 7 products & launched 6 products in 2017,   February 10, 2018
  Stempeutics signs co-development pact with Alkem for Stempeucel to treat knee osteoarthritis,   February 08, 2018
  EMA accepts Teva Pharma's fremanezumab MAA to treat migraine in adults,   February 05, 2018
  Mylan introduces generic Sustiva tablets in Us market to treat HIV,   February 03, 2018
  EMA committee recommends marketing approval for GSK’s Shingrix for prevention of shingles in adults aged 50 and over,   January 29, 2018
  Cipla gets US FDA approval to market generic Viread tablets,   January 29, 2018
  EU grants marketing approval for Adcetris to treat adults with CD30-positive CTCL after at least one prior systemic therapy,   January 24, 2018
  EC grants marketing authorization for Mvasi to treat certain types of cancer,   January 20, 2018
  Diplomat Pharmacy begins distribution of Exelixis' Cabometyx to treat patients with advanced RCC,   January 17, 2018
  Mundipharma to market Grünenthal’s pain drug, Tramal in China,   January 16, 2018
  EC grants marketing nod to Roche’s Ocrevus for relapsing forms of MS & primary progressive MS,   January 13, 2018

Pharmabiz: PPM_150x60_2018
Copyright © 2016 Saffron Media Pvt. Ltd |